Shared decision making supported by patient decision aids for prostate cancer screening and treatment

Prostate cancer is an important problem among aging men in developed countries. Decisions about prostate cancer screening and treatment are characterized by multiple reasonable options and appear to be “close calls”, where the personal preferences of patients are important. Shared decisionmaking bet...

Full description

Bibliographic Details
Main Author: Michael J. Barry
Format: Article
Language:Spanish
Published: Universidad Complutense de Madrid 2010-10-01
Series:Psicooncologia
Subjects:
Online Access:http://revistas.ucm.es/index.php/PSIC/article/view/15876
id doaj-e57cde6cd76840efae16e0fdb0aa3bf9
record_format Article
spelling doaj-e57cde6cd76840efae16e0fdb0aa3bf92020-11-25T00:02:25ZspaUniversidad Complutense de MadridPsicooncologia1696-72401988-82872010-10-017225726715891Shared decision making supported by patient decision aids for prostate cancer screening and treatmentMichael J. BarryProstate cancer is an important problem among aging men in developed countries. Decisions about prostate cancer screening and treatment are characterized by multiple reasonable options and appear to be “close calls”, where the personal preferences of patients are important. Shared decisionmaking between patient and clinician is increasingly recognized as an ideal model for such “preference sensitive” choices involving screening, diagnosis, and therapy. Many randomized trials of decision aids for prostate cancer screening have consistently shown improvements in decision quality as well as lower interest in and uptake of PSA testing when patients are well informed. In contrast, more research is needed on the effect of decision aids on prostate cancer treatment decisions. However, given the evidence of effectiveness available at present, research is most urgently needed on how to routinely implement patient decision aids for PSA screening, as well as other fateful decisions including prostate cancer treatment, in clinical practice.http://revistas.ucm.es/index.php/PSIC/article/view/15876Toma de decisión compartidaAyudas a la decisiónScreening cáncer de próstataTratamiento de cáncer de próstataAntígeno específico cáncer de próstata (PSA)
collection DOAJ
language Spanish
format Article
sources DOAJ
author Michael J. Barry
spellingShingle Michael J. Barry
Shared decision making supported by patient decision aids for prostate cancer screening and treatment
Psicooncologia
Toma de decisión compartida
Ayudas a la decisión
Screening cáncer de próstata
Tratamiento de cáncer de próstata
Antígeno específico cáncer de próstata (PSA)
author_facet Michael J. Barry
author_sort Michael J. Barry
title Shared decision making supported by patient decision aids for prostate cancer screening and treatment
title_short Shared decision making supported by patient decision aids for prostate cancer screening and treatment
title_full Shared decision making supported by patient decision aids for prostate cancer screening and treatment
title_fullStr Shared decision making supported by patient decision aids for prostate cancer screening and treatment
title_full_unstemmed Shared decision making supported by patient decision aids for prostate cancer screening and treatment
title_sort shared decision making supported by patient decision aids for prostate cancer screening and treatment
publisher Universidad Complutense de Madrid
series Psicooncologia
issn 1696-7240
1988-8287
publishDate 2010-10-01
description Prostate cancer is an important problem among aging men in developed countries. Decisions about prostate cancer screening and treatment are characterized by multiple reasonable options and appear to be “close calls”, where the personal preferences of patients are important. Shared decisionmaking between patient and clinician is increasingly recognized as an ideal model for such “preference sensitive” choices involving screening, diagnosis, and therapy. Many randomized trials of decision aids for prostate cancer screening have consistently shown improvements in decision quality as well as lower interest in and uptake of PSA testing when patients are well informed. In contrast, more research is needed on the effect of decision aids on prostate cancer treatment decisions. However, given the evidence of effectiveness available at present, research is most urgently needed on how to routinely implement patient decision aids for PSA screening, as well as other fateful decisions including prostate cancer treatment, in clinical practice.
topic Toma de decisión compartida
Ayudas a la decisión
Screening cáncer de próstata
Tratamiento de cáncer de próstata
Antígeno específico cáncer de próstata (PSA)
url http://revistas.ucm.es/index.php/PSIC/article/view/15876
work_keys_str_mv AT michaeljbarry shareddecisionmakingsupportedbypatientdecisionaidsforprostatecancerscreeningandtreatment
_version_ 1725437908925546496